Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Clothier

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Drug Safety|October 1, 2025
Statistical Methods for Multi-jurisdictional Australian Vaccine Safety Investigations of Rare Adverse EventsHannah J Morgan, Lauren Bloomfield, Hazel J Clothier, et al.
BMJ Paediatrics Open|September 2, 2022
Myocarditis and myopericarditis cases following COVID-19 mRNA vaccines administered to 12-17-year olds in Victoria, AustraliaDaryl R Cheng, Hazel J Clothier, Hannah J Morgan, et al.
Vaccine|November 10, 2021
Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, AustraliaSally F Gordon, Hazel J Clothier, Hannah Morgan, et al.
The Medical Journal of Australia|December 10, 2024
Clinical phenotype of COVID-19 vaccine-associated myocarditis in Victoria, 2021-22: a cross-sectional studyJulia Smith, Silja Schrader, Hannah Morgan, et al.
The Medical Journal of Australia|November 21, 2012
Guillain-Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case seriesNigel W Crawford, Allen Cheng, Nick Andrews, et al.
Neurology|March 12, 2026
Incidence of Childhood Stroke and Association With Recent Infection: A Population-Based Study Using Linked DataLachlan L Dalli, Muideen T Olaiya, Hannah J Morgan, et al.
Human Vaccines & Immunotherapeutics|April 26, 2022
Victorian Specialist Immunisation Services (VicSIS) - bolstering adult clinics for COVID-19 vaccinesSally F Gordon, Elise Virah Sawmy, Eleanor Duckworth, et al.
Vaccine|February 13, 2024
COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individualsK Faksova, D Walsh, Y Jiang, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Drug Safety|October 1, 2025
Statistical Methods for Multi-jurisdictional Australian Vaccine Safety Investigations of Rare Adverse EventsHannah J Morgan, Lauren Bloomfield, Hazel J Clothier, et al.
BMJ Paediatrics Open|September 2, 2022
Myocarditis and myopericarditis cases following COVID-19 mRNA vaccines administered to 12-17-year olds in Victoria, AustraliaDaryl R Cheng, Hazel J Clothier, Hannah J Morgan, et al.
Vaccine|November 10, 2021
Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, AustraliaSally F Gordon, Hazel J Clothier, Hannah Morgan, et al.
The Medical Journal of Australia|December 10, 2024
Clinical phenotype of COVID-19 vaccine-associated myocarditis in Victoria, 2021-22: a cross-sectional studyJulia Smith, Silja Schrader, Hannah Morgan, et al.
The Medical Journal of Australia|November 21, 2012
Guillain-Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case seriesNigel W Crawford, Allen Cheng, Nick Andrews, et al.
Neurology|March 12, 2026
Incidence of Childhood Stroke and Association With Recent Infection: A Population-Based Study Using Linked DataLachlan L Dalli, Muideen T Olaiya, Hannah J Morgan, et al.
Human Vaccines & Immunotherapeutics|April 26, 2022
Victorian Specialist Immunisation Services (VicSIS) - bolstering adult clinics for COVID-19 vaccinesSally F Gordon, Elise Virah Sawmy, Eleanor Duckworth, et al.
Vaccine|February 13, 2024
COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individualsK Faksova, D Walsh, Y Jiang, et al.
Pageof 8